Jae Cheol Hwang
Papers
1
Total Citations
10
H-Index
1
About
Dr. Jae Cheol Hwang is a urologic surgeon and researcher whose work centers on the management of renal tumors, particularly angiomyolipomas (AMLs). His most cited study, "Varying Outcomes among Patients with Large Angiomyolipomas according to the Treatment Method," directly compares the efficacy of selective arterial embolization (SAE) against robotic-assisted nephron-sparing surgery (NSS). This retrospective analysis of 25 patients provides critical, real-world data guiding clinical decision-making for large, complex renal masses. By rigorously evaluating outcomes between these two minimally invasive approaches, Dr. Hwang’s work helps urologists tailor treatment to optimize patient safety and renal function preservation. With 10 citations, this paper has already informed subsequent discussions on AML management. Dr. Hwang’s research contributes to the broader field of urologic oncology by clarifying the trade-offs between embolization and robotic surgery, a key consideration for patients with challenging tumor presentations. His focus on comparative effectiveness underscores a commitment to evidence-based, patient-centered care in the treatment of renal angiomyolipomas.
Research Focus
Key Achievements
Top Papers
- 1